Type to search

Amphista Therapeutics Appoints CBO, Beverley Carr | Pharmtech Focus
Amphista Therapeutics Expands Research Team by Appointing Martin O'Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry | Pharmtech Focus